Skip to main content

Table 3 Preliminary data on baseline patients' characteristics

From: Design and implementation of the canadian kidney disease cohort study (CKDCS): A prospective observational study of incident hemodialysis patients

  Cohort patients, N(%)
N 1074
Age* 62 (50, 73)
Male 662 (62)
Race 1074
   White 813 (76)
   Aboriginal 81 (8)
   East Asian 47 (4)
   South Asian 42 (4)
   Other 91 (8)
Marital status 937
   Married 581 (62)
   Single 163 (17)
   Divorced 104 (11)
   Widow 89 (9)
BMI, kg/m 2 * 26 (22, 31)
Cause of ESRD 916
   Diabetic nephropathy 380 (41.5)
   Glomerulonephritis 154 (16.8)
   Hypertensive/ischemic renal disease 68 (7.4)
   Polycystic kidney disease 49 (5.3)
   Other 265 (28.9)
Comorbidity  
Arrhythmia 214 (20.9)
Cancer 156 (14.4)
Cerebrovascular disease 130 (12.7)
Congestive heart failure 202 (20.2)
Chronic lung disease 125 (12.7)
Claudication 131 (13.3)
Coronary disease 481 (46.7)
Dementia 28 (2.8)
Diabetes mellitus 515 (50.7)
Diabetic retinopathy 224 (23)
HBV 30 (2.9)
HCV 39 (3.8)
HIV 2 (.2)
Hypertension 785 (86.5)
Pericarditis 27 (2.7)
Peripheral neuropathy 239 (24.2)
Peripheral vascular disease 209 (20.6)
Prior cardiac arrest 20 (2)
Psychiatric illness 148 (15)
Seizure disorder 34 (3.4)
ECG 310 (28.7)
   Normal 61 (5.6)
   Abnormal 142 (13.1)
   No result 107 (9.9)
ECHO 320 (29.6)
   Normal 14 (1.3)
   Abnormal 50 (4.6)
   No result 256 (23.7)
Current Smoker 154 (15.7)
CLINICAL MANAGEMENT  
Satellite HD unit 201 (18.7)
Type of access 510
   AVF 138 (27.1)
   PTFE 10 (2)
   Non tunnel CVC 42 (8.2)
   Tunnel CVC 308 (60.4)
LABORATORY MEASURES*  
Albumin, g/L 34 (30, 37)
Calcium, mmol/L 2.2 (2, 2.3)
Calcium X phosphate, mmol2/L2 3.6 (2.9, 4.5)
Creatinine, μmol/L 534 (424, 682)
Ferritin, μg/L 252 (136, 472)
Hemoglobin, g/L 99 (89, 109)
Phosphate, mmol/L 1.6 (1.2, 1.9)
PTH, pmol/L 26.2 (10.7, 45.8)
Transaturation, % 24 (17, 31)
Urea, mmol/L 18.6 (14.6, 23.5)
Kt/V 1.4 (1.2, 1.7)
Distance to Nephrologist, km 482
≤50 387 (80.3)
51 - 100 43 (8.9)
101 - 200 30 (6.2)
> 200 33 (6.8)
  1. *Median (interquartile range)
  2. all clinics outside of Edmonton, Calgary and Vancouver considered satellite unit
  3. HD Hemodialysis; BMI body mass index; ESRD end-stage renal disease; HBV Hepatitis B virus; HCV Hepatitis C virus; HIV Human immunodeficiency virus; ECG electrocardiogram; ECHO echocardiogram; AVF Arterial Venous Fistula; PD Peritoneal dialysis; PTFE Polytetrafluoroethylene; CVC Central venous catheters; PTH parathyroid hormone